Alnylam Pharmaceuticals Inc at Bank of America Global Healthcare Conference (Virtual) Transcript
Okay, good morning, everyone, and good afternoon for those of you joining from London. My name is Tazeen Ahmad. I am one of the senior mid biotech analysts here at Bank of America. It's my pleasure to welcome you once again to our global healthcare conference, London though virtual this year. We're hoping to go back in person in future years. It's my pleasure to have with me our next presenting company, Alnylam. And presenting for Alnylam this morning is, of course, a familiar face, CEO, John Maraganore. John, good morning. Thank you for joining us again.
Good morning. And good afternoon to colleagues in Europe.
So I think at this point, there's not that many people who don't know about Alnylam. But for those who might be kind of not healthcare specialists, John, can you give a couple of minutes overview of the Company, its platforms? And then we can
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
